Astana Biomed Group, an authorized Abcam distributor in Central Asia

Signaling Pathway

Lorglumide sodium salt, cholecystokinin receptor antagonist (ab141319)

Description:
Potent, selective cholecystokinin receptor antagonist
Application:
Reactivity:
Conjugate:

LoVo nuclear extract lysate (ab14859)

Description:
LoVo nuclear extract lysate
Application:
Reactivity:
Conjugate:

LRRK2-IN-1, LRRK2 inhibitor (ab254524)

Description:
Potent and selective inhibitor of the Parkinson’s disease kinase LRRK2
Application:
Reactivity:
Conjugate:

Luffariellolide, phospholipase A2 (PLA2) inhibitor. Agonist at RARalpha (ab141759)

Description:
Potent phospholipase A2 (PLA2) inhibitor. Agonist at RARα
Application:
Reactivity:
Conjugate:

LY2874455, FGF/FGFR inhibitor (ab216313)

Description:
Potent FGF/FGFR inhibitor
Application:
Reactivity:
Conjugate:

M344, HDAC inhibitor (ab141401)

Description:
HDAC inhibitor. Shows selectivity for HDAC6.
Application:
Reactivity:
Conjugate:

MCF7 nuclear extract lysate (ab14860)

Description:
MCF7 nuclear extract lysate
Application:
Reactivity:
Conjugate:

MCF7 nuclear extract lysate (estradiol treated) (ab14861)

Description:
MCF7 nuclear extract lysate (estradiol treated)
Application:
Reactivity:
Conjugate:

Methazolamide, Carbonic anhydrase inhibitor (ab145585)

Description:
Potent, cell-permeable carbonic anhydrase inhibitor
Application:
Reactivity:
Conjugate:

MG-132 (Ethanol Solution), proteasome inhibitor (ab147047)

Description:
Cell-permeable, potent, reversible proteasome inhibitor
Application:
Reactivity:
Conjugate:
© 2021 Astana Biomed Group LLP. All rights reserved.